Nelly Failloux possesses extensive experience in the pharmaceutical and biotechnology sectors, having held key leadership roles at Servier from March 2018 to April 2023, including Global Asset Leader for Neurology and Oncology, where strategic oversight of innovative therapeutic assets was prioritized. Previously, Nelly contributed to Roche from August 2004 to October 2015, managing oncology clinical trials and supporting research in transplantation. An early career as a Research Engineer at Coletica involved developing advanced dermocosmetic ingredients. Nelly is currently pursuing an Executive MBA in Strategy & Management of Health Industries from ESSEC Business School and holds a PMP® certification from the Project Management Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices